The EVAPORATE trial provides important mechanistic data on plaque characteristics that have relevance to the REDUCE-IT results and clinical use of icosapent ethyl.

Budoff, Matthew; Lakshmanan, Suvasini; Bhatt, Deepak L

Budoff, Matthew; Lakshmanan, Suvasini; Bhatt, Deepak L.

Afiliação

Budoff M; Department of Medicine, Lundquist Institute at Harbor-UCLA Medical Center, 1124 W Carson Street, Torrance, CA 90502, USA.
Lakshmanan S; Department of Medicine, Lundquist Institute at Harbor-UCLA Medical Center, 1124 W Carson Street, Torrance, CA 90502, USA.
Bhatt DL; Brigham and Women's Hospital Heart & Vascular Center, Harvard Medical School, 75 Francis Street Boston, MA 02115, USA.

Eur Heart J ; 42(31): 3025-3026, 2021 08 17.

Article em En | MEDLINE | ID: mdl-33970207

Assuntos

Hipertrigliceridemia; Placa Aterosclerótica; Ácido Eicosapentaenoico/análogos & derivados; Humanos; Placa Aterosclerótica/tratamento farmacológico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hipertrigliceridemia / Placa Aterosclerótica Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google